Realistic expectations for AI drug discovery

A new open-source AI agent called OpenClaw has set Silicon Valley buzzing and with a single line of code, anyone can use it. Does this free tool threaten the AI business models behind trillion-dollar Big Tech IPOs, and could it signal a looming AI bubble? Plus, Danny Fortson and Katie Prescott also speak to Jurgi Camblong, founder and CEO of SOPHiA Genetics, about how AI is already being used in hospitals to decode complex medical data and transform cancer diagnosis and care.

Photo: Getty

Clip: @AlexFinn on X.com

Hosted on Acast. See acast.com/privacy for more information.